The Pathology of Cholestasis

Seminars in Liver Disease

Volumn 24, Issue 1, 2004, Pages 21-42

  Li, Melissa K ^a   Crawford, James M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bile; Biliary tree; Cholestasis; Hepatocyte; Pathology

Indexed keywords

BILE; BILE DUCT; BILE DUCT ATRESIA; CHOLESTASIS; FIBROGENESIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTRAHEPATIC BILE DUCT; KUPFFER CELL; LIVER BIOPSY; LIVER CELL; LIVER FUNCTION; LIVER PARENCHYMA; LIVER SINUSOID; MYOFIBROBLAST; PHAGOCYTOSIS; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; BILE DUCTS; BIOPSY; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; CHOLESTASIS; FEMALE; HEPATOCYTES; HUMANS; INFANT; INFANT, NEWBORN; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 1942454787     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-823099     Document Type: Review

References (116)

1. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003;83: 633-671
2. Crawford JM. The role of vesicle-mediated transport pathways in hepatocellular bile secretion. Semin Liver Dis 1996;16:169-189
3. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-1227
4. Accatino L, Pizarro M, Solis N, et al. Differential expression of canalicular membrane Ca2+/Mg(2+)-ecto-ATPase in estrogen-induced and obstructive cholestasis in the rat. J Lab Clin Med 2000;136:125-137
5. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr 1996; 16:179-203
6. Suchy FJ, Balistreri WF, Hung J, Miller P, Garfield SA. Intracellular bile acid transport in rat liver as visualized by electron microscope autoradiography using a bile acid analogue. Am J Physiol 1983;245:G681-G689
7. Buscher HP, Schramm U, MacNelly S, Kurz G, Gerok W. The acinar location of the sodium-independent and the sodium-dependent component of taurocholate uptake. A histoautoradiographic study of rat liver. J Hepatol 1991;13: 169-178
8. Stieger B, Hagenbuch B, Landmann L, et al. In situ localization of the hepatocytic Na+ cotransporting polypeptide in rat liver. Gastroenterology 1994;107:1781-1787
9. Aiso M, Takikawa H, Yamanaka M. Biliary excretion of bile acids and organic anions in zone 1- and zone 3-injured rats. Liver 2000;20:38-44
10. Layden TJ, Boyer JL. Influence of bile acids on bile canalicular membrane morphology and the lobular gradient in canalicular size. Lab Invest 1978;39:110-119
11. Wilton JC, Chipman JK, Lawson CJ, Strain AJ, Coleman R. Periportal- and perivenous-enriched hepatocyte couplets: differences in canalicular activity and in response to oxidative stress. Biochemistry 1993;292:773-779
12. Strazzabosco M, Spirli C, Okoliczanyi L. Pathophysiology of the intrahepatic biliary epithelium. J Gastroenterol Hepatol 2000;15:244-253
13. Alpini G, McGill JM, LaRusso NF. The pathobiology of biliary epithelia. Hepatology 2002;35:1256-1268
14. Benedetti A, Di Sario A, Marucci L, et al. Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. Am J Physiol 1997;272: G1416-G1424
15. Saxena R, Theise ND, Crawford JM. Microanatomy of the human liver: exploring the hidden interfaces. Hepatology 1999;30:1339-1346
16. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998;28:323-331
17. Theise ND, Saxena R, Portmann BC, et al. Canals of Hering and hepatic stem cells in humans. Hepatology 1999;30: 1425-1433
18. Crawford JM. Development of the intrahepatic biliary tree. Semin Liver Dis 2002;22:213-226
19. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997;38: 552-570
20. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001;33:738-750
21. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990;99:466-477
22. Roskams T, Theise ND, Desmet V, et al. Hepatology 2004; (In press)
23. Wang X, Foster M, Al-Dhalimy M, et al. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci USA 2003;100(Suppl 1):11881-11888
24. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422:897-901
25. Hatch HM, Zheng D, Jorgensen ML, Petersen BE. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002;4:339-351
26. Kollet O, Shivtiel S, Chen YQ et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112:160-169
27. Landing BH, Wells TR. Considerations of some architectural properties of the biliary tree and liver in childhood. In: Abramowsky CR, Bernstein J, Rosenberg HS eds. Transplantation Pathology-Hepatic Morphogenesis. Perspectives in Pediatric Pathology, Vol. 14. Basel: S. Karger; 1991:122-142
28. Ludwig J, Ritman EL, LaRusso NF, Sheedy PF, Zumpe G. Anatomy of the human biliary system studied by quantitative computer-aided three-dimensional imaging techniques. Hepatology 1998;27:893-899
29. Miyake M, Okudaira M, Sato T, Kitagawa M, Hisauchi T. The blood vessels of the liver. Nippon Byori Gakkai Kaishi. Trans Soc Pathol Jap 1960;49:589-632
30. Popper H, Szanto PB. Intrahepatic cholestasis (cholangiolitis). Gastroenterology 1956;31:683-700
31. Anderson J. On hemorrhage from the umbilicus after the separation of the fetus. Boston Med Surg J 1850;41:440-442
32. Green RM, Crawford JM. Hepatocellular cholestasis: pathobiology and histological outcome. Semin Liver Dis 1995;15:372-389
33. Zollner G, Fickert P, Zenz R, et al. Hepatobiliary tranpsorter expression in percutaneous liver biopsies of patients with cholestatic liver disease. Hepatology 2001;33: 633-646
34. Vox TA, Hooiveld GJ, Koning H, et al. Up-regulation of the multidrug resistance genes, Mrpl and Mdr1b, and down-regulation of the organic anion tranpsorter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998;28:1637-1644
35. Trauner M, Arrese M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-264
36. Lee JM, Trauner M, Soroka CJ, et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000;118:163-172
37. Soroka CJ, Lee JM, Azzaroki F, Boyer JL. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 2001; 33:783-791
38. Hirohashi T, Suzuki H, Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 1999;274:15181-15185
39. Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein3 (Mrp3). J Biol Chem 2000;275:2905-2910
40. Ogawa K, Suzuki H, Hirohashi T, et al. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 2000;278:G438-G446
41. Grambihler A, Higuchi H, Bronk SF, Gores GJ. cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J Biol Chem 2003;278:26831-26837
42. Nagore N, Howe S, Boxer L, Scheuer PJ. Liver cell rosettes: structural differences in cholestasis and hepatitis. Liver 1989; 9:43-51
43. Clayton PT, Casteels M, Mieli-Vergani G, Lawson AM. Familial giant cell hepatitis with law bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inbom error of bile acid synthesis. Pediatr Res 1995;37: 424-431
44. Alagille D, Odievre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental and sexual devel opment, and cardiac murmur. J Pediatr 1975;86:63-71
45. Crawford JM. Cellular and molecular biology of the inflamed liver. Curr Opin Gastroenterol 1997;13:175-185
46. Crawford JM, Boyer JL. Clinicopathology conferences: inflammation-induced cholestasis. Hepatology. 1998;28:253-260
47. Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta". Hum Pathol 1982;13:19-24
48. Tavoloni N, Schaffner F. The intrahepatic biliary epithelium in the guinea pig: is hepatic artery blood flow essential in maintaining its function and structure? Hepatology 1985;5: 666-672
49. Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest 2004;84:153-159
50. Terada R, Yamamoto K, Hakoda T, et al. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 2003;83:665-672
51. Tuchweber B, Desmouliere A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 1996;74:265-278
52. Desmouliere A, Darby I, Costa AMA, et al. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 1997;76:765-778
53. Uchio K, Tuchweber B, Manabe N, et al. Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat heaptic stellate cells and portal fibroblasts. Lab Invest 2002;82:619-628
54. Kinnman N, Francoz C, Barbu V, et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003;83:163-173
55. Crawford JM. Cirrhosis. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the Liver, 4th ed. Philadelphia: WB Saunders; 2002:575-619
56. Hammel P, Couvelard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancratitis and stenosis of the common bile duct. N Engl J Med 2001;344:418-423
57. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15:572-577
58. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61
59. Mackay IR, Whittingham S, Fida S, et al. The peculiar autoimmunity of primary biliary cirrhosis. Immunol Rev 2000;174:226-237
60. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: association with class II major histocompatibility antigens. Hepatology 1987;7:889-892
61. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994;20:698-701
62. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically based population study. J Hepatol 1999;30:402-407
63. Saxena R, Hytiroglou P, Thung SN, Theise ND. Destruction of canals of Hering in primary biliary cirrhosis. Hum Pathol 2002;33:983-988
64. Scheuer PJ. Ludwig Symposium on biliary disorders-part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc 1998;73: 179-183
65. Vleggaar FP, van Buuren HR, Zondervan PE, ten Kate FJW, Hop WCJ. Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant. Gut 2001;49: 276-281
66. Goodman ZD, McNally PR, Davis KR, Ishak KG. Auto-immune cholangitis: a variant of primary biliary cirrhosis-clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995;40:1232-1242
67. Heathcote J. Variant syndromes of autoimmune hepatitis. Clin Liver Dis 2002;6:381-396
68. Kim WR, Lindor KD, Locke GR III, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631-1636
69. Burt AD. Primary biliary cirrhosis and other ductopenic diseases. Clin Liver Dis 2002;6:363-380
70. Zein CO, Lindor KD. Primary sclerosing cholangitis. Semin Gastrointest Dis 2001;12:103-112
71. Bhathal PS, Powell LW. Primary intrahepatic obliterating cholangitis: a possible variant of "sclerosing cholangitis." Gut 1969;10:886-893
72. Liu C, Crawford JM. Graft-versus-host disease of the liver. In: Ferrara JLM, Deeg J, Burakoff S, eds. Graft Versus Host Disease, 3rd ed. New York: Marcel Dekker; 2004: (In press)
73. Teshima T, Ferrara JL. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 2002;39:15-22
74. Snover DC. Acute and chronic graft-versus-host disease: histopathological evidence for two distinct pathogenetic mechanisms. Hum Pathol 1984;15:202-205
75. Snover DC. Wiesdorf SA, Ramsay NK, McClave P, Kersey JH. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology 1984;4:123-130
76. Tanaka M, Umihara J, Shimmoto K, et al. The pathogenesis of graft-versus-host reaction in the intrahepatic bile duct. An immunohistochemical study. Acta Pathol Jpn 1989;39:648-655
77. Strasser SI, Shulman HM, Flowers ME, et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000;32:1265-1271
78. Fujii N, Takenaka K, Shinagawa K, et al. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001;27:1007-1010
79. Akpek G, Boitnott JK, Lee LA, et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002;100:3903-3907
80. Malik AH, Collins RH, Saboorian H, Lee WM. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis. Am J Gastroenterol 2001;96:588-590
81. Vierling JM. Immune disorders of the liver and bile duct. Gastroenterol Clin North Am 1992;21:427-449
82. Andersen CB, Horn T, Sehested M, Junge J, Jacobsen N. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients. Transplant Proc 1993;25:1250-1254
83. Yeh KH, Hsieh HC, Tang JL, et al. Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome. Bone Marrow Transplant 1994;14:319-321
84. Yau JC, Zander AR, Srigley JR, et al. Chronic graft-versus-host disease complicated by micronodular cirrhosis and esophageal varices. Transplantation 1986;41:129-130
85. Knapp AB, Crawford JM, Rappeport JM, Gollan JL. Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1987;92:513-519
86. Stechschulte DJ Jr, Fishback JL, Emami A, Bhatia P. Secondary biliary cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1990;98:223-225
87. Urban CH, Deutschmann A, Kerbl R, et al. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2002;30:535-537
88. Kroumpouzos G. Intrahepaticcholestasis of pregnancy: what's new. J Eur Acad Dermatol Venereol 2002;16:316-318
89. Reyes H. Intrahepatic cholestasis. A puzzling disorder of pregnancy (review). J Gastroenterol Hepatol 1997;12:211-216
90. Germain AM, Carvajal JA, Glasinovic JC, Kato S, Williamson C. Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder. J Soc Gynecol Investig 2002;9: 10-14
91. Bacq Y, Sapey T, Brechot MC, et al. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997;26:358-364
92. Heikkinen J, Maentausta O, Ylostalo P, Janne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981; 88:240-245
93. Gendrot C, Bacq Y, Brechot MC, Lansac J, Andres C. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet 2003;40:e32
94. Mullenbach R, Linton KJ, Wiltshire S, et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003;40:e70
95. Jacquemin E, De Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120:1448-1458
96. Lammert F, Marschall H-U, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis, and management. J Hepatol 2000;33:1012-1021
97. Ishak KG, Sharp HL, Schwarzenberg SJ. Metabolic errors and liver disease. In: MacSween RMN, Burt AD, Portmann BC, et al.eds. Pathology of The Liver, 4th ed. London: Churchill Livingstone; 2002:155-255
98. Jonas MM, Perez-Atayde AR. Liver disease in infancy and childhood. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Diseases of the Liver, 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003:1459-1496
99. Jevon GP, Dimmick JE. Histopathologic approach to metabolic liver disease: part 1. Pediatr Dev Pathol 1998;1: 179-199
100. Jevon GP, Dimmick JE. Histopathologic approach to metabolic liver disease: part 2. Pediatr Dev Pathol 1998;1:261-269
101. Knisely AS, Crawford JM. Pediatric and metabolic liver disease. In: Odze RD, Goldblum JR, Crawford JM eds. Pathology of the Gastrointestinal Tract, Pancreas, Liver and Biliary Tree Philadelphia: WB Saunders; 2004:979-998
102. Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? Hepatology 2002;35:1297-1304
103. Cocjin J, Rosenthal P, Buslon V, et al. Bile ductule formation in fetal, neonatal, and infant livers compared with extra-hepatic biliary atresia. Hepatology 1996;24:568-574
104. Koukoulis G, Mieli-Vergani G, Portmann B. Infantile liver giant cells: immunohistological study of their proliferative state and possible mechanisms of formation. Pediatr Dev Pathol 1999;2:353-359
105. Raweily EA, Gibson AA, Burt AD. Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology 1990;17:521-527
106. Desmet VJ. Ludwig symposium on biliary disorders - part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998;73:80-89
107. Low Y, Vijayhan V, Tan CEL. The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: an immunohistochemical study. J Pediatr 2001;139:320-322
108. Tan CEL, Moscoso GJ. The developing human biliary system at the porta hepatis level between 29 days and 8 weeks of gestation: A way to understanding biliary atresia. Part 1. Pathol Int 1994;44:587-599
109. Torbenson M, Wang J, Abraham S, Maitra A, Boitnott J. Bile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia. Am J Surg Pathol 2003;27:1454-1457
110. Talbot IC, Mowat AP. Liver disease in infancy: histological features and relationship to alpha-antitrypsin phenotype. J Clin Pathol 1975;28:559-563
111. Amarapurkar A, Somers S, Knisely AS, Portmann BC. Steatosis of periportal hepatocytes is associated with alpha-1-antitrypsin storage disorder at presentation in infancy. Lab Invest 2002;82:309A-310A
112. Deutsch GH, Sokol RJ, Stathos TH, Knisely AS. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol 2001;4:559-563
113. Kahn E. Paucity of interlobular bile ducts: Arteriohepatic dysplasia and nonsyndromic duct paucity. Perspect Pediatr Pathol 1991;14:168-215
114. Alagille D. Intrahepatic biliary atresia (hepatic ductular hypoplasia). In: Berenberg SR, ed. Liver Diseases in Infancy and Childhood Dordrecht, The Netherlands: Martinez Nijhoff; 1976:129-142
115. Kahn E, Markowitz J, Aiges H, Daum F. Human ontogeny of the bile duct to portal space ratio: clinical and laboratory findings in 10 cases. J Pediatr Gastroenterol Nutr 1997;24: 44-48
116. Braier J, Ciocca M, Latalla A, et al. Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis. Med Pediatr Oncol 2002;38:178-182